This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

J. L. POOL, M.D.; T. J. C. VON STORCH, M.D.; WILLIAM G. LENNOX, M.D.

Arch Intern Med. 1936;57(1):32-45.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

During the last few years a half-dozen reports have appeared in the French and German literature concerning the value of ergotamine tartrate (gynergen) in the treatment of migraine. A summary of the literature as well as of the therapeutic results obtained with forty-five of his own patients has been made recently by Lennox.¹ All the authors who have studied the subject agree that in the great majority of patients suffering from migraine headache the injection of ergotamine tartrate cuts short the attack, an action which seems to be specific, or nearly so, for headache of the migraine type.

The authors who have reported these dramatic clinical results have offered theories but little or no evidence concerning the mechanism by which ergotamine acts. A study of the physiologic effects of ergotamine on patients during a migraine headache might, we thought, uncover the cause of the relief and hence suggest the . . . [Full Text PDF of this Article]

Author Affiliations
BOSTON

From the Neurological Service of the Boston City Hospital and the Department of Neuropathology of the Harvard Medical School.

Footnotes
This investigation was aided by a grant of the Josiah Macy Jr. Foundation.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati     What's this?